These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30891674)

  • 1. Effects of low-dose combined oral contraceptives and protein S K196E mutation on anticoagulation factors: a prospective observational study.
    Miyoshi T; Oku H; Asahara S; Okamoto A; Kokame K; Nakai M; Nishimura K; Otsuka F; Higashiyama A; Yoshimatsu J; Miyata T
    Int J Hematol; 2019 Jun; 109(6):641-649. PubMed ID: 30891674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Oedingen C; Scholz S; Razum O
    Thromb Res; 2018 May; 165():68-78. PubMed ID: 29573722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C; Duijkers I; Parke S; Mellinger U; Serrani M; Junge W
    Drugs R D; 2011; 11(2):159-70. PubMed ID: 21679006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
    Winkler UH; Hölscher T; Schulte H; Zierleyn JP; Collet W; Schindler AE
    Gynecol Endocrinol; 1996 Aug; 10(4):265-71. PubMed ID: 8908527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined oral contraceptive. Risks and adverse effects in perspective.
    Bagshaw S
    Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the oral contraceptive pill on protein S and antithrombin-III levels in Malaysian women.
    Wong KK; Ng SC; Koong PL
    Med Sci Res; 1992 Jun 16-30; 20(12):439-40. PubMed ID: 12288974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
    Bremme K; Hamad RR; Berg E; Strandberg K; Stenflo J
    Thromb Res; 2012 Oct; 130(4):636-9. PubMed ID: 22154243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.
    Short M
    Clin Drug Investig; 2009; 29(3):153-9. PubMed ID: 19243208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added benefits and user satisfaction with a low-dose oral contraceptive containing drospirenone: results of three multicentre trials.
    Bitzer J; Paoletti AM
    Clin Drug Investig; 2009; 29(2):73-8. PubMed ID: 19133702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
    Mohamed AM; El-Sherbiny WS; Mostafa WA
    Int J Gynaecol Obstet; 2011 Aug; 114(2):145-8. PubMed ID: 21669426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN; Koh SC; Viegas OA; Ratnam SS
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.
    van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Büller HR; Meijer K
    Blood; 2011 Aug; 118(8):2055-61; quiz 2375. PubMed ID: 21659542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y; Foidart JM; Pintiaux A; Minon JM; Fauser BC; Cobey K; Coelingh Bennink HJ
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.